BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22057407)

  • 1. Factors related to recurrence of paradoxical cerebral embolism due to patent foramen ovale.
    Fukuoka T; Dembo T; Nagoya H; Kato Y; Yasuko O; Deguchi I; Maruyama H; Horiuchi Y; Takeda H; Tanahashi N
    J Neurol; 2012 Jun; 259(6):1051-5. PubMed ID: 22057407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale.
    Tobe J; Bogiatzi C; Munoz C; Tamayo A; Spence JD
    Can J Cardiol; 2016 Aug; 32(8):986.e9-986.e16. PubMed ID: 26952158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
    Varotto L; Bregolin G; Paccanaro M; De Boni A; Bonanno C; Perini F
    Cerebrovasc Dis; 2020; 49(2):124-134. PubMed ID: 32289794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism-A Prospective Observational Study.
    Vindiš D; Hutyra M; Šaňák D; Král M; Čecháková E; Littnerová S; Adam T; Přeček J; Hudec Š; Ječmenová M; Táborský M
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):357-364. PubMed ID: 29031497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominence of the Eustachian valve in paradoxical embolism.
    Vale TA; Newton JD; Orchard E; Bhindi R; Wilson N; Ormerod OJ
    Eur J Echocardiogr; 2011 Jan; 12(1):33-6. PubMed ID: 20813791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
    Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
    JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial Doppler for stratification of high-risk morphology of patent foramen ovale in patients with cryptogenic stroke.
    Chino S; Mochizuki Y; Mizuma K; Ichikawa S; Miyazaki H; Hachiya R; Toyosaki E; Ota M; Fukuoka H; Yamochi T; Ono K; Shinke T
    Heart Vessels; 2022 Dec; 37(12):2119-2127. PubMed ID: 35701559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
    Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
    Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ischemic stroke associated with patent foramen ovale: hospital database analysis].
    Belopasova AV; Kulesh AA; Mekhryakov SA; Chazov SA; Syromyatnikova LI; Chechetkin AO; Karshieva AR; Kadykov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3. Vyp. 2):13-19. PubMed ID: 36950816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
    Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
    J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Small Cortical Cerebellar Infarctions on MRI are Associated with Patent Foramen Ovale in Young Cryptogenic Stroke.
    Renard D; Ion I; Ricci JE; Mura T; Thouvenot E; Wacongne A
    Cerebrovasc Dis; 2020; 49(1):105-109. PubMed ID: 32062661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?
    Rigatelli G; Aggio S; Cardaioli P; Braggion G; Giordan M; Dell'avvocata F; Chinaglia M; Rigatelli G; Roncon L; Chen JP
    JACC Cardiovasc Interv; 2009 Jul; 2(7):655-62. PubMed ID: 19628189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale and cryptogenic stroke: a matter of age?
    Handke M; Harloff A; Bode C; Geibel A
    Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale and cryptogenic stroke.
    Nakanishi K; Yoshiyama M; Homma S
    Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
    J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.